Enrish Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.80 M
- Revenue Growth 193.60%
- Profit Growth 187.75%
- Ebitda 33.57%
- Net Worth 7.03%
- Total Assets 60.68%
About Enrish Pharmaceutical
Enrish Pharmaceutical Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 May 2016 (Eight years and nine months 19 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.80 M.
Manishkumar Mishra, Shrikant Rane, Vijaykumar Moon, and One other member serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2016PTC280805
- Company No.
280805
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Enrish Pharmaceutical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manishkumar Mishra  | Director | 07-May-2016 | Current |
| Shrikant Rane | Director | 01-Dec-2016 | Current |
| Vijaykumar Moon | Additional Director | 03-Feb-2022 | Current |
| Sushant Bala | Additional Director | 03-Feb-2022 | Current |
Financial Performance of Enrish Pharmaceutical.
Enrish Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 193.6% increase. The company also saw a substantial improvement in profitability, with a 187.75% increase in profit. The company's net worth moved up by a moderate rise of 7.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enrish Pharmaceutical?
Unlock access to Enrish Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.80 M
₹0
Charges Breakdown by Lending Institutions
- Punjab And Maharashtra Co-Operative Bank Limited : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2018 | Punjab And Maharashtra Co-Operative Bank Limited | ₹0.50 M | Open |
| 30 Mar 2017 | Punjab And Maharashtra Co-Operative Bank Limited | ₹0.30 M | Open |
How Many Employees Work at Enrish Pharmaceutical?
Unlock and access historical data on people associated with Enrish Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enrish Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enrish Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
